Amiodarone is highly effective in suppressing ventricular and supraven
tricular tachyarrhythmias. The most serious adverse reaction is pulmon
ary toxicity. completely understood. Several forms of pulmonary diseas
e occur including interstitial pneumonitis, fibrosis or organizing pne
umonia. The incidence is generally lower with lower maintenance doses
(less than or equal to 300 mg/d). There are no adequate predictors of
pulmonary toxicity due to amiodarone. The diagnosis:of amiodarone-indu
ced pulmonary: toxicity is one of exclusion. Treatment consists primar
ily of stopping amiodarone application. Corticosteroid therapy can be
life-saving for severe cases and for patients in whom withdrawal of am
iodarone is not possible.